BIOLINERX
Facebook
|
Twitter
|
Linkedin
| Careers | Contact Us
search

Investor relations home

BioLineRx is a clinical-stage biopharmaceutical company focused on oncology and immunology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization.

BioLineRx's leading therapeutic candidates are: BL-8040, a cancer therapy platform, which has successfully completed a Phase 2a study for relapsed/refrac... More >>

Therapeutic pipeline
Title
Download Documentation  Pipeline
Upcoming events
DateTitle
10/19/18
through
10/23/18
ESMO 2018 Congress
01/07/19
through
01/09/19
JPM/Biotech Showcase
What's new
DateTitle
10/08/18
Download Documentation BioLineRx Company presentation
Get help downloading or viewing the above file types


Interview with Philip Serlin, CEO
December 2016